Company news
China Nt Pharma Group Co., Ltd. (HKEX:1011) news
China Nt Pharma Group Co., Ltd. news releases on 6ix. Latest, Sep 29, 2026: Notification Letter and Request Form to Non-Registered Holder
Press releases & updates
Notification Letter and Request Form to Non-Registered Holder
September 29, 2026
Notification Letter and Reply Form to Registered Shareholder
September 29, 2026
2026 Interim Report
September 29, 2026
CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE
June 17, 2026
SUPPLEMENTAL ANNOUNCEMENT RETIREMENT OF AUDITOR
June 11, 2026
China NT Pharma : PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
April 30, 2021
China NT Pharma : PROFIT WARNING SUPPLEMENTAL ANNOUNCEMENT
August 6, 2020
China NT Pharma : VOLUNTARY ANNOUNCEMENT SHUSI APPROVED IN CONSISTENCY EVALUATION
February 20, 2020
China NT Pharma : APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF MEMBER OF BOARD COMMITTEES
December 31, 2019
China NT Pharma : RESIGNATION OF EXECUTIVE AND NON-EXECUTIVE DIRECTORS AND CHANGE OF CHIEF FINANCIAL OFFICER
November 29, 2019
China NT Pharma : MONTHLY PROGRESS UPDATE IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION IN RESPECT OF THE ACQUISITION AND SUBSCRIPTION OF SHARES AND CONVERTIBLE BONDS OF HONG KONG WD PHARMACEUTICAL CO., LIMITED (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (3) APPLICATION FOR WHITEWASH WAIVER
October 29, 2019
China NT Pharma : EXTENSION OF CONDITIONS PRECEDENT LONG STOP DATE AND FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION IN RESPECT OF THE ACQUISITION AND SUBSCRIPTION OF SHARES AND CONVERTIBLE BONDS OF HONG KONG WD PHARMACEUTICAL CO., LIMITED (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (3) APPLICATION FOR WHITEWASH WAIVER
September 30, 2019
China NT Pharma : FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION IN RESPECT OF THE ACQUISITION AND SUBSCRIPTION OF SHARES AND CONVERTIBLE BONDS OF HONG KONG WD PHARMACEUTICAL CO., LIMITED (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (3) APPLICATION FOR WHITEWASH WAIVER
September 6, 2019
China NT Pharma : PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES AND PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
April 27, 2017
China NT Pharma : Supplemental Agreement in Relation to Proposed Issuance of Convertible Preference Shares
April 24, 2017
China NT Pharma : (1) Proposed Issue of Convertible Preference Shares (2) Proposed Grant of Specific Mandate t…
April 20, 2017
China NT Pharma : Annual Results Announcement for the Year ended 31 December 2016
March 22, 2017
China NT Pharma : VOLUNTARY ANNOUNCEMENT NT BIOPHARMA OBTAINED NEW GMP CERTIFICATION FROM CFDA PRODUCTION AND SALES OF NATIONAL CLASS 1.1 NEW DRUG “XI DI KE” WILL OFFICIALLY COMMENCE
March 10, 2017
China NT Pharma : Announcement of Approval of Xi Di Ke (Uroacitides Injection), National Class 1.1 New Drug to…
January 4, 2017
China NT Pharma : Voluntary Announcement - NT Pharma Successfully Makes Payment of Acquisition on Miacalcic I…
December 19, 2016
China NT Pharma : VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENT AND INTENTION TO CONDUCT ON-MARKET SHARE REP…
December 15, 2016